Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
This is the group’s first NoC approval in Canada
The submission is supported by positive results from the Phase 3 AMPLIFY trial
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Vasograin Plus represents a major advancement in the treatment of migraine
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Subscribe To Our Newsletter & Stay Updated
